Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases (Q44706480)
Jump to navigation
Jump to search
scientific article published on 18 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases |
scientific article published on 18 June 2007 |
Statements
1 reference
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases (English)
1 reference
Chen-Hsiang Lee
1 reference
Chishih Chu
1 reference
Jien-Wei Liu
1 reference
Yi-Shung Chen
1 reference
Chiung-Jung Chiu
1 reference
Lin-Hui Su
1 reference
18 June 2007
1 reference
1 reference
Identifiers
1 reference